Company intelligence / Profile preview

Sanvia Capital

Miami Beach, Florida, United Statesyoutube.com ↗

Ownership: Private
Development stage: Other

Overview

Sanvia Capital is an active biopharmaceutical hedge fund focused on investing in innovative small and mid-cap public biotech and pharmaceutical companies. The fund applies scientific and clinical expertise to identify undervalued or overlooked opportunities at the frontier of value transformation within life sciences. It was originally started as a Millennium Partners platform company before becoming independent in November 2020.

Industry: Investors

Beyond the preview

Go deeper on Sanvia Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanvia Capital.

Explore the full profile